EC
BSX icon

Elequin Capital’s Boston Scientific BSX Stock Holding History

Elequin Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-482
Closed -$40.4K – 535
2024
Q3 		$40.4K Buy
482
+248
+106% +$19.6K ﹤0.01% 91
2024
Q2 		$18K Buy
+234
New +$17.1K ﹤0.01% 94
2022
Q3 		– Sell
-935
Closed -$35K – 572
2022
Q2 		$35K Sell
935
-66
-7% -$2.69K 0.01% 154
2022
Q1 		$44K Buy
+1,001
New +$43.4K 0.01% 66

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Elequin Capital's BSX Position: Q4 2024 in Review

Elequin Capital sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 482 shares — an estimated $40.4K sold.

Elequin Capital first reported a position in BSX in Q1 2022 and held it in 4 quarters. The position peaked at $44K in Q1 2022. 1,512 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

  • Elequin Capital reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
  • Elequin Capital sold 482 Boston Scientific shares in Q4 2024, an estimated $40.4K.
  • Elequin Capital first reported a position in Boston Scientific in Q1 2022 and held it in 4 quarters.
  • Elequin Capital's Boston Scientific position peaked at $44K in Q1 2022.
  • 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on Elequin Capital's 13F filing for Q4 2024, filed 18 Feb 2025.